| Phase III Trial Begins for GAMMAGARD LIQUID Plus rHuPH20 in ... - PR Newswire (press release) |
|
|
Immune Globulin Intravenous (Human) products have been reported to be associated with renal dysfunction, acute renal failure, osmotic nephrosis, and death. ... |